Expert Oversight - Expert Witness - Litigation Support - Personal Pharmacy Consulting - Legal Nurse Consulting


The speed of change in new drug development, evidence based medicine and best practice require a strong base of understanding and an ongoing study of new medication innovations and utilization. Whether you are an attorney seeking out a better understanding of a complex pharmacy related case or an individual in search of clarity for a parent with multiple medications, you will find help here.

The time will arise when a detailed explanation of drug related topics is needed and this will be the time for a targeted discussion. As an expert in the field of pharmacy, I have aided many professionals with the evaluation of documents with or without a written opinion. Microconsulting provides the opportunity for attorneys and individuals to consult without a signed contract. This conversation will establish the need for an expert, support of your case or general knowledge of the practice of pharmacy.

When searching for services such as; expert witness, expert pharmacy witness, expert pharmacist, pharmacist expert witness, consulting pharmacist, or legal nurse consultant you have located the needed resources. With the experience of working on various pharmacy-legal cases, you will be assured that the fact that years of clinical and practical experience will aid your understanding of complex drug related topics.

Follow the links to the pages above as they will lead you to the services provided and the expertise available. Rather you choose to call or send a note, you will be pleased with the responsiveness and level of service offered. Attorneys, pharmaceutical companies, insurance companies and individuals will find the legal consulting services necessary to achieve their goals and outcomes with Grant Clinical Consulting working with them.

Thank you for visiting,

Dr. Wayne Grant

Dr. Wayne H


Dr. Wayne H. Grant is a registered pharmacist, in good standing, in the State of Ohio, since 1990. He received his Bachelor of Pharmacy degree from Ohio Northern University, Ada, Ohio in 1990, a Doctor of Pharmacy degree from the University of Florida, Gainesville, Florida in 2007 and an MBA from Kent State University in 2016.  Employed by a hospice in Cleveland, Ohio, current clinical practice is in hospice and palliative care targeting disease state management in multiple areas including but not limited to; cardiology, gastrointestinal, geriatrics, nephrology, oncology, psychiatry, and pulmonology.

Dr. Grant has prepared and delivered educational classes to nursing professionals on topics of pain management, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, dementia and cancer related problems. Sitting on multiple committees including the pharmacy and therapeutics, renal and quality, He is able to promote the importance and appropriateness of pharmacy intervention.

Paramount to his current practice is detailed understanding of pain management. Dosage routes from oral, intravenous, intrathecal and others in conjunction with strong opioids and adjuvants garner much of Dr. Grant’s attention.

Expertise in long-term, institutional, infusion and retail practice compose of an extensive understanding of the various pharmacy sectors. As an adjunct clinical assistant professor, with the University of Florida, College of Pharmacy, Department of Pharmacotherapy and Translational Research, Dr. Grant utilizes current evidence-based medicine in order to foster best practice. Additionally, he teaches pharmacy students from Ohio Northern University and The Ohio State University who are completing clinical rotations in their final year prior to graduation.

Dr. Grant has delivered local, state, national and international speaking programs reflective of the fundamental practice of pharmacy. As a peer reviewer for the American Journal of Health-System Pharmacy, he has provided feed back on articles which will determine future drug therapies. A history of clinical practice, management, and education culminate present day understanding of the pharmacy profession.


Provide a service based on the fundamental practice of pharmacy. Through review, interpretation and application of evidence base medicine, clients will become knowledgeable of specific medication choices. Integrating the latest in research and practice standards will aid in achieving this objective. The cornerstone to this mission is providing a clear, open and honest discussion of the individual circumstance while maintaining respect for the client’s privacy and choice regardless of the opinions and recommendations offered.


The mechanism of delay-nausea (>24hours) involves stimulation of neuroreceptors other than serotonin. Dopamine mediations dominate this type of nausea. This leads to the benefit seen with phenothiazines (chlorpromazine, promethazine) and butyrophenone (haloperidol). The use of 5HT-3 antagonists, such as ondansetron is not beneficial in this phase of emesis control as it lacks dopaminergic activity. The use of other drugs such as dexamethasone, metoclopramide, droperidol and olanzapine may provide relief.


Methadone which is an agonist of mu and delta, and an antagonist at the NMDA (N-methyl-D-aspartate) receptor offers a unique treatment option. Pain negatively effects of the NMDA receptor through what is postulated as an interaction on the excitatory transmitters (glutamate and aspartate) resulting in central sensitization. The use of a NMDA blocking agent is thought to reduce or interfere with the discharge threshold making it not as sensitive and able to restrain transmittal of pain signals.